U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07145333) titled 'Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms' on Aug. 14.
Brief Summary: Explore the relationship between drug target topoisomerase I gene single nucleotide polymorphisms and Topotecan therapeutic-effects in patients with small cell lung cancer, based on Oxford precisely sequencing drug targets' genes.
Explore the relationship between drug target CYP4503A4 gene single nucleotide polymorphisms and Topotecan side-effects in patients with small cell lung cancer, based on Oxford precisely sequencing drug targets' genes.
Study Start Date: Aug. 12
Study Type: INTERVENTIONAL
Condition:
SCLC...